The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2017 Supervisory Review and Evaluation Process

21 Dec 2017 07:00

RNS Number : 9912Z
Permanent TSB Group Holdings PLC
21 December 2017
 

21 December 2017

 

PERMANENT TSB GROUP HOLDINGS PLC (the "Bank")

 

2017 Supervisory Review and Evaluation Process

 

 

The Bank has been notified by the European Central Bank of the outcome of its 2017 Supervisory Review and Evaluation Process ("SREP") which will be effective from 1 January 2018.

 

The decision requires that the Bank maintains a Common Equity Tier 1 ("CET 1") ratio of 9.825% and a Total Capital ratio of 13.325% until 31 December 2018 on a transitional basis.

 

The CET 1 ratio of 9.825% consists of a Pillar 1 Capital Requirements Regulation ("CRR") requirement of 4.50%, a Pillar 2 Requirement ("P2R") of 3.45% (unchanged from the current year) and a Capital Conservation Buffer ("CCB") of 1.875% (reflecting a further year's phase-in).

 

The Total Capital ratio of 13.325% consists of a Minimum Own Funds CET1 requirement of 9.825% and a Minimum Own Funds Tier 1 and Tier 2 requirement of 3.50%.

 

The 2017 SREP requirement compares to the Bank's transitional CET1 ratio of 17.5%[1] and a Total Capital ratio of 18.7%1 at 30 September 2017.

 

In addition, the 2017 SREP decision advises that the Bank is prohibited from paying out dividends to shareholders.

 

Separately, the Bank has recently been de-designated as an Other Systemically Important Institution ("O-SII") by the Central Bank of Ireland. As a result, the previously guided O-SII capital requirement of 0.50% by 2020 does not apply to the Bank.

 

Both the SREP capital requirements (including the prohibition on payment of dividends) and O-SII buffers are subject to annual review.

 

 

Capital Requirements

Effective From

1.1.2018 to 31.12.2018

Effective From

1.1.2017 to

31.12.2017

Pillar 1 CET 1

4.50%

4.50%

Pillar 2 Requirement (P2R)

3.45%

3.45%

Capital Conservation Buffer

1.875%

1.25%

Total CET 1 Requirement / Maximum Distributable Amount Trigger

9.825%

9.20%

Tier 1

1.50%

1.50%

Tier 2

2.00%

2.00%

Total Capital Requirement

13.325%

12.70%

 

 

 

Ends

 

For further information, please contact:

 

Eamonn Crowley

Chief Financial Officer

eamonn.crowley@permanenttsb.ie

+353 1 669 5354

Rajesh ManirajanHead of Investor Relationsrajesh.manirajan@permanenttsb.ie+353 1 669 5622

Ray GordonGordon MRMptsb@gordonmrm.ie+353 87 241 7373

 

 

Note on forward-looking information:

This Announcement contains forward-looking statements, which are subject to risks and uncertainties because they relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Group or the industry in which it operates, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements referred to in this paragraph speak only as at the date of this Announcement. The Group undertakes no obligation to release publicly any revision or updates to these forward-looking statements to reflect future events, circumstances, unanticipated events, new information or otherwise except as required by law or by any appropriate regulatory authority.

 


[1] Includes profits earned in Q3 2017 which is subject to regulatory approval.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STROKKDPABDDCBB
Date   Source Headline
1st Nov 201611:00 amRNSHolding(s) in Company
27th Oct 20167:00 amRNSSale Agreed for Non-Core UK Assets
26th Oct 20163:00 pmRNSDirectorate Change (Chairman)
27th Sep 201610:16 amRNSDirector Declaration
27th Sep 201610:00 amRNSDirectorate Change
27th Jul 20163:00 pmRNSHalf-year Report
27th Jul 20167:00 amRNSHalf-year Report
27th Jul 20167:00 amRNSHalf-Year Results Commentary
26th Jul 20165:00 pmRNSDirector Declaration
26th Jul 20164:00 pmRNSDirectorate Change
20th May 20164:00 pmRNSHolding(s) in Company
20th May 20169:05 amRNSHolding(s) in Company
18th May 201612:00 pmRNSDirector Declaration
11th May 20167:00 amRNSTrading Statement
27th Apr 20164:30 pmRNSAppointment of Senior Independent Director
20th Apr 20164:00 pmRNSResult of AGM
19th Apr 201611:15 amRNSAppointment of Chief Risk Officer
18th Mar 20169:00 amRNSNotice of AGM
16th Mar 20164:30 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSAnnual Financial Report
9th Mar 20167:00 amRNSAnnual Results Commentary
29th Feb 20164:37 pmRNSPrice Monitoring Extension
4th Feb 201611:30 amRNSHolding(s) in Company
12th Jan 201612:00 pmRNSDirectorate Change
22nd Dec 20154:26 pmRNSDirectorate Change
30th Nov 20154:35 pmRNSPrice Monitoring Extension
10th Nov 20157:00 amRNSTrading Statement
3rd Nov 20154:56 pmRNSDirector/PDMR Shareholding
9th Oct 20153:00 pmRNSSenior Management Change
18th Aug 20153:00 pmRNSSenior Management Changes
29th Jul 20153:00 pmRNSHalf Yearly Report
29th Jul 20157:00 amRNSHalf Yearly Report
28th Jul 20159:00 amRNSMortgage Redress Programme
28th Jul 20158:30 amRNSPreliminary 2015 Half Year Results
23rd Jul 20154:15 pmRNSHigh Court approval of capital reduction
17th Jul 20153:00 pmRNSSenior Management Change
9th Jul 20153:50 pmRNSDeleveraging Update
1st Jul 20157:00 amRNSStandard Variable Rate Mortgage Pricing Update
24th Jun 20154:15 pmRNSHolding(s) in Company
5th Jun 201512:05 pmRNSHolding(s) in Company
2nd Jun 201510:00 amRNSTotal Voting Rights
29th May 20154:40 pmRNSHolding(s) in Company
21st May 20154:15 pmRNSHolding(s) in Company
18th May 20157:00 amRNSResult of Open Offer
6th May 20154:15 pmRNSHolding(s) in Company
5th May 201511:30 amRNSCompletion of Placing
5th May 201511:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.